ARX:ASX
Aroa Biosurgery Ltd
A$ ०.५०
arrow_upward
+१.०२%(+०.००५०) 1D
नोभेम्बर २०, १०:२०:१६ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$ ०.५०
High
A$ ०.५०
Low
A$ ०.५०
Mkt. cap
१६.९५ करोड
Avg. vol.
२.५९ लाख
Volume
२६.५१ हजार
P/E ratio
४७.१४
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
Open
A$ ०.५०
High
A$ ०.५०
Low
A$ ०.५०
Mkt. cap
१६.९५ करोड
Avg. vol.
२.५९ लाख
Volume
२६.५१ हजार
P/E ratio
४७.१४
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
News stories
From web sources and news partners
Yahoo Finance
·
५२ मिनेट पहिले
S&P 500, Nasdaq, Dow End Lower As Anthropic Trading Debut Fails To Provide Adequate Confidence — ANT, META, AAPL, GME In Focus
Traders Union
·
१ घण्टा पहिले
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
ChartMill
·
१ घण्टा पहिले
S&P 500 After-Hours Movers: Nov. 19, 2026
FXStreet
·
२ घण्टा पहिले
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd